Human GPC3/Glypican 3 HEK293T Stable Cell Line

Introduction to Human GPC3/Glypican 3 HEK293T Stable Cell Line

Human GPC3/Glypican 3 HEK293T Stable Cell Line: Structure, Activity, and Application

Human GPC3/Glypican 3 (GPC3) is a glycosylphosphatidylinositol (GPI)-anchored cell surface protein that plays an important role in cell growth and development. It is expressed in various tissues and is highly expressed in the liver, lung, and kidney. GPC3 has been identified as a potential therapeutic target for various diseases, including cancer. In order to study the function and potential therapeutic applications of GPC3, stable cell lines expressing this protein have been developed, such as the Human GPC3/Glypican 3 HEK293T Stable Cell Line.

Structure of Human GPC3/Glypican 3

GPC3 is a 580 amino acid protein with a molecular weight of approximately 65 kDa. It is composed of a highly conserved core protein and a GPI anchor that attaches it to the cell membrane. The core protein consists of a signal peptide, a heparan sulfate (HS) attachment site, and two HS attachment domains. The HS attachment domains are important for GPC3’s interaction with HS chains of other cell surface proteins, such as fibroblast growth factors (FGFs). This interaction is crucial for the regulation of cell growth and differentiation.

Activity of Human GPC3/Glypican 3

GPC3 has been shown to have multiple functions in various cellular processes. It is involved in the regulation of cell proliferation, differentiation, and migration. It has been reported to interact with multiple growth factors, including FGFs, Wnts, and Hedgehog proteins, and modulate their signaling pathways. GPC3 has also been shown to play a role in the development of various organs, such as the liver, lung, and kidney. Dysregulation of GPC3 has been linked to various diseases, including cancer.

Application of Human GPC3/Glypican 3 HEK293T Stable Cell Line

The Human GPC3/Glypican 3 HEK293T Stable Cell Line is a valuable tool for studying the function and potential therapeutic applications of GPC3. This stable cell line has been engineered to express GPC3 at a stable level, allowing for consistent and reproducible results. The HEK293T cell line is a commonly used cell line for protein expression studies, making it a suitable host for GPC3 expression.

One of the major applications of the Human GPC3/Glypican 3 HEK293T Stable Cell Line is in the study of GPC3 as a potential therapeutic target for cancer. GPC3 has been found to be overexpressed in various types of cancer, including hepatocellular carcinoma, lung cancer, and ovarian cancer. The stable expression of GPC3 in this cell line allows for the investigation of its role in cancer development and progression. It can also be used to screen for potential drugs that target GPC3 and inhibit its function.

The Human GPC3/Glypican 3 HEK293T Stable Cell Line is also useful for studying the interaction between GPC3 and other cell surface proteins, such as FGFs. This can provide insights into the mechanisms of GPC3’s role in regulating cell growth and differentiation. Additionally, this stable cell line can be used to investigate the effects of GPC3 on the development of various organs, such as the liver, lung, and kidney.

Flow cytometry is a commonly used technique to analyze the expression of cell surface proteins. The Human GPC3/Glypican 3 HEK293T Stable Cell Line can be used in flow cytometry experiments to quantify the expression of GPC3 on the cell surface. This can be useful in studying the regulation of GPC3 expression and its potential role in disease development.